Home Page

Action required: Please refresh your browser

We have recently implemented some changes that require a hard refresh of your browser: Please hold down the CTRL-key and press the F5 key.
After a successful hard refresh, this message should not appear anymore.

More details about this topic are available here »

News in the Life Sciences Industry
Results 4661 - 500 out of 500 displayed.
« 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25
Reset ↻

VitalHub Announces Q4 2023 Conference Call Date

Read more ››

By: GlobeNewswire - 14 Mar 2024

Related companies: VitalHub Corp

ZyVersa Therapeutics' CEO, Stephen C. Glover to Participate in a Panel Discussion Titled “Inflammation Illuminated,”at Benzinga’s Virtual Healthcare Summit 2024 on March 20, 2024

Read more ››

By: GlobeNewswire - 14 Mar 2024

Related companies: ZyVersa Therapeutics, Inc.

60 Degrees Pharmaceuticals Announces Communication from the FDA of Intention to Respond to Tafenoquine-Babesiosis Trial Protocol Submission in April, 2024

Read more ››

By: GlobeNewswire - 14 Mar 2024

Related companies: 60° Pharmaceuticals, LLC

iSpecimen Reports Full Year 2023 Results

Read more ››

By: GlobeNewswire - 14 Mar 2024

Related companies: iSpecimen

Konica Minolta Healthcare Sponsors SPIE Best Student Paper Award

Read more ››

By: GlobeNewswire - 14 Mar 2024

Related companies: Konica Minolta Healthcare Americas, Inc.

MediWound to Report Fourth Quarter and Full Year 2023 Financial Results

Read more ››

By: GlobeNewswire - 14 Mar 2024

Related companies: MediWound Ltd.

Keros Therapeutics Announces U.S. FDA Fast Track Designation for KER-050 in Lower-Risk Myelodysplastic Syndromes

Read more ››

By: GlobeNewswire - 14 Mar 2024

Related companies: Keros Therapeutics, Inc.

Achieve Life Sciences to Announce Fourth Quarter and Year-End 2023 Financial Results and Host Conference Call and Webcast on March 28, 2024

Read more ››

By: GlobeNewswire - 14 Mar 2024

Related companies: Achieve Life Sciences, Inc.

Lirum Therapeutics Announces Positive Data on LX-101, a Novel Clinical-Stage Targeted Therapy Demonstrating Potent Preclinical Activity Against IGF-Related Cancers, Accepted for Presentation at the 2024 ESMO Sarcoma and Rare Cancers Congres

Read more ››

By: GlobeNewswire - 14 Mar 2024

Related companies: Lirum Therapeutics, Inc.

Recce Pharmaceuticals Doses Next Cohort in Phase I/II Trial of RECCE® 327 for Urinary Tract Infections and Urosepsis

Read more ››

By: GlobeNewswire - 14 Mar 2024

Related companies: Recce Pharmaceuticals Ltd

DiagnaMed Strengthening Intellectual Property Support for CERVAI™ Brain Health AI Solution

Read more ››

By: GlobeNewswire - 14 Mar 2024

Related companies: DiagnaMed Holdings Corp.

Goodness Growth Holdings to Release Fourth Quarter and Full Year 2023 Results on March 28, 2024

Read more ››

By: GlobeNewswire - 14 Mar 2024

Autonomix Completes First Three Patient Procedures in Human Clinical Trial Targeting Multi-Billion-Dollar Pancreatic Cancer Market

Read more ››

By: GlobeNewswire - 14 Mar 2024

Related companies: Autonomix Medical, Inc.

GeneDx to Present Data at the 2024 American College of Medical Genetics (ACMG) Annual Meeting Demonstrating Clinical Superiority of its Exome, Paving the Way for the Future of Genomics

Read more ››

By: GlobeNewswire - 14 Mar 2024

Related companies: GeneDx, LLC

Telomir Pharmaceuticals Uses AI Testing Models to Show its Lead Product Candidate’s Potential in DNA Age Reversal Science

Read more ››

By: GlobeNewswire - 14 Mar 2024

Related companies: Telo Genomics Corp. | Telomir Pharmaceuticals, Inc.

Nexalin Technology Commences Sales of Gen-2 Neurostimulation Device to New Mental Health Center in Oman Dedicated to Nexalin’s Technology

Read more ››

By: GlobeNewswire - 14 Mar 2024

Related companies: Nexalin Technology Inc

Scorpius Holdings Accepted as a Member of the US Government’s BioMaP-Consortium

Read more ››

By: GlobeNewswire - 14 Mar 2024

Milestone Scientific Commences Sales of CompuFlo® Epidural Disposables within Omaha Pain Physicians

Read more ››

By: GlobeNewswire - 14 Mar 2024

Related companies: Milestone Scientific, Inc.

180 Life Sciences Regains Full Compliance with Nasdaq Minimum Bid Price Requirement

Read more ››

By: GlobeNewswire - 14 Mar 2024

Related companies: 180 Life Sciences Corp.

GRI Bio Announces Notice of Allowance for Canadian Patent Covering Proprietary Natural Killer T (NKT) Cell Modulators

Read more ››

By: GlobeNewswire - 14 Mar 2024

Related companies: GRI Bio Inc.

« 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25

to the top ↑